Cupid shares jump 5%, multibagger stock turns Rs 1 lakh investment into Rs 87 lakh in just 3 years

Cupid's shares continued to deliver skyrocketing returns for its investors, jumping another 5% on Tuesday and bringing its three-year returns to a whopping 8,700%.

The shares of the condom-maker were trading at Rs 217.99 apiece on the NSE on Tuesday. The stock was trading at a mere Rs 2.5 per share back in July 2023. If an investor invested Rs 1 lakh to buy shares of the company, their total shareholding would be worth a whopping Rs 87 lakh today.

While the shares have fallen around 4% in one week, Cupid shares jumped 33% in one month and are up more than 102% in 2026 so far. The stock has delivered over 740% returns in just one year.


The company manufactures and supplies male and female condoms, water-based lubricant jelly and IVD kits. It operates a manufacturing facility in Sinnar near Nashik, about 200 km from Mumbai. It says it is the first company globally to receive prequalification from the World Health Organisation and the United Nations Population Fund for supplying both male and female condoms.

What lies ahead for Cupid share price?

Cupid’s earnings trajectory is encouraging, but the stock has appreciated far more rapidly than the underlying business, said Harshal Dasani, Business Head at INVasset PMS. He noted that the company has delivered strong revenue and profit growth, backed by rising institutional exports, capacity expansion and a broader personal care portfolio. Management’s guidance also suggests confidence in sustaining growth over the coming quarters. Fundamentally, the operating momentum remains constructive, according to the analyst.

The bigger question now is valuation. After an extraordinary rally over the past year, the stock is pricing in a large part of the expected growth, leaving limited room for execution missteps, Dasani said. From a technical perspective, the sharp rejection from recent highs, followed by an equally swift recovery, suggests momentum-driven participation rather than steady institutional accumulation, he added.

The Rs 195 to Rs 200 zone is emerging as an important support area, while Rs 220 to Rs 226 remains a key resistance band, according to the analyst, who further said, “As long as earnings continue to justify expectations, the long-term story remains intact. However, at current valuations, the risk-reward appears more balanced than compelling, and sustained execution will be the key factor that determines the next phase of the stock’s journey.”

Also read: Cupid shares reclassified to BSE Group ‘A’

Cupid Q1 business update

Cupid at the end of June said it is on track to report revenue exceeding Rs 150 crore in the first quarter of FY27, which it described as one of the strongest quarterly performances in its history. Aided by the strong start to the financial year and improved visibility across international and domestic markets, the company has also raised its FY27 revenue guidance.

The company now expects FY27 revenue to stand at more than Rs 660 crore, up from its earlier guidance of Rs 600 crore, implying an upward revision of at least 10%. Cupid said the revised outlook is backed by its diversified business model, an expanding global opportunity pipeline and increasing operating scale across multiple business verticals.

Cupid also continues to make steady progress in its In Vitro Diagnostics (IVD) business. While management's near-term growth estimates for this segment remain conservative, it believes the business has the potential to become a meaningful contributor over the coming years, supported by regulatory approvals, new product launches, and continued commercialisation efforts, the company said.

Also read: 13 stocks surged up to 225% in just 3 months

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)